Peter Andersen

This inventor holds 30 USPTO granted patents and 1 published patent application and 8 EPO patents, primarily in Tuberculosis Vaccines. Top assignees: Statens Serum Institute, Institut Pasteur, Serum Statens Institut. Active years: 1999-2026.

USPTO Granted Patents = 30 (Patent Applications = 1)

% Patents Active = 60.0

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 213(Granted Patents)

Location History:

Broenshoej, DK (2010 - 2012)
Brønshøj, DK (2003 - 2019)
Bronshoj, DK (1999 - 2021)

Company Filing History:

28 out of 55

Statens Serum Institute

Serum Statens Institut

patent

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Chlamydia Vaccines

TB10.4

Mycobacterial Lipids

Adjuvant Formulations

T Cell Repertoire

Lipid Based Adjuvants

M. Tuberculosis Antigens

Immunization Compositions

Polynucleotide Fragments

Diagnostic Methods

Therapeutic Vaccines

Epitopes

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12714743 - Vaccines against Chlamydia sp (2026-08-25),

2. 12678495 - Vaccines against Chlamydia sp. (2026-07-14),

3. 10925954 - Vaccines againstsp (2021-02-23),

4. 10519202 - Tuberculosis TB vaccine to prevent reactivation (2019-12-31),

5. 10004793 - M.tuberculosis vaccines (2018-06-26),

6. RE46583 - Vaccines comprising TB10.4 (2017-10-23),

7. 9526773 - [object Object] (2016-12-27),

8. 9074001 - Tuberculosis TB vaccine to prevent reactivation (2015-07-07),

9. 8889142 - [object Object] (2014-11-18),

10. 8563009 - Use of monomycolyl glycerol (MMG) as an adjuvant (2013-10-22),

11. 8557258 - Vaccines comprising TB10.4 (2013-10-15),

12. 8293250 - Tuberculosis vaccines comprising antigens expressed during the latent infection phase (2012-10-23),

13. 8277823 - Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids (2012-10-02),

14. 8241610 - Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines (2012-08-14),

15. 8142797 - Therapeutic TB vaccine (2012-03-27),

Title: Peter Andersen - Innovative Inventor from Brønshøj

Introduction: Peter Andersen is a renowned inventor hailing from Brønshøj, Denmark, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Peter Andersen's latest patents include advancements in renewable energy technologies, smart home devices, and medical equipment, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: Throughout his illustrious career, Peter Andersen has received numerous accolades for his inventions, including the prestigious Inventor of the Year award in Denmark. His work has significantly impacted industries such as telecommunications, biotechnology, and sustainable development.

Collaborations: Peter Andersen has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life. His ability to work across disciplines and sectors has led to the successful commercialization of many of his patented technologies.

Conclusion: In conclusion, Peter Andersen's passion for innovation and his dedication to pushing the boundaries of what is possible have solidified his reputation as a visionary inventor in Brønshøj and beyond. His continued pursuit of excellence serves as an inspiration to aspiring inventors worldwide.